Literature DB >> 25707449

Cyclic adenosine 5'-diphosphoribose (cADPR) mimics used as molecular probes in cell signaling.

Liangren Zhang1, Jianbo Yue, Li-He Zhang.   

Abstract

Cyclic adenosine 5'-diphosphate ribose (cADPR) is a second messenger in the Ca(2+) signaling pathway. To elucidate its molecular mechanism in calcium release, a series of cADPR analogues with modification on ribose, nucleobase, and pyrophosphate have been investigated. Among them, the analogue with the modification of the northern ribose by ether linkage substitution (cIDPRE) exhibits membrane-permeate Ca(2+) agonistic activity in intact HeLa cells, human T cells, mouse cardiac myocytes and neurosecretory PC12 cell lines; thus, cIDPRE and coumarin-caged cIDPRE are valuable probes to investigate the cADPR-mediated Ca(2+) signal pathway.
Copyright © 2015 The Chemical Society of Japan and Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  calcium; cell cycle; nucleotides; signal transduction; structure-activity relationships

Mesh:

Substances:

Year:  2015        PMID: 25707449     DOI: 10.1002/tcr.201402072

Source DB:  PubMed          Journal:  Chem Rec        ISSN: 1528-0691            Impact factor:   6.771


  2 in total

1.  Synthesis of cyclic N (1)-pentylinosine phosphate, a new structurally reduced cADPR analogue with calcium-mobilizing activity on PC12 cells.

Authors:  Ahmed Mahal; Stefano D'Errico; Nicola Borbone; Brunella Pinto; Agnese Secondo; Valeria Costantino; Valentina Tedeschi; Giorgia Oliviero; Vincenzo Piccialli; Gennaro Piccialli
Journal:  Beilstein J Org Chem       Date:  2015-12-22       Impact factor: 2.883

2.  New Linear Precursors of cIDPR Derivatives as Stable Analogs of cADPR: A Potent Second Messenger with Ca2+-Modulating Activity Isolated from Sea Urchin Eggs.

Authors:  Stefano D'Errico; Emy Basso; Andrea Patrizia Falanga; Maria Marzano; Tullio Pozzan; Vincenzo Piccialli; Gennaro Piccialli; Giorgia Oliviero; Nicola Borbone
Journal:  Mar Drugs       Date:  2019-08-17       Impact factor: 5.118

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.